Literature DB >> 21154308

The efficacy of Tc-99m sestamibi for sentinel node mapping in breast carcinomas: comparison with Tc-99m antimony sulphide colloid.

Ramin Sadeghi1, Seyed Rasoul Zakavi, Mohammad Naser Forghani, Kamran Aryana, Vahid Reza Dabbagh Kakhki, Narjes Khatoon Ayati, Fatemeh Homaee Shandiz, Mohammad Reza Ghavamnasiri, Mohammed Keshtgar.   

Abstract

BACKGROUND: To study the value of periareolar intra-dermal injection of Tc-99m sestamibi (MIBI) for sentinel node mapping in breast carcinoma.
MATERIAL AND METHODS: Fifty patients with early-stage breast cancer were included in our study. 17.5 MBq Tc-99m-MIBI was injected intradermally to 25 patients and the remainders were injected with the same dose of Tc-99m-antimony sulphide colloid. Anterior and lateral static images were taken at 2 minutes. If sentinel lymph node was not detected, delayed imaging by up to 180 minutes was carried out. The patients were operated on 2-4 hours post-injection. Sentinel lymph node biopsy was performed by the aid of gamma probe and blue dye during surgery.
RESULTS: In the Tc-99m-MIBI group, 23 patients had lymph nodes on scintigraphy images, and sentinel nodes were detected during surgery in all 23 patients. In the Tc-99m-antimony sulphide colloid group, 24 patients had lymph nodes on scintigraphy images, and sentinel nodes were identified during surgery in 24 patients.
CONCLUSIONS: We concluded that 99mTc-MIBI is a suitable radiopharmaceutical for sentinel node detection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21154308

Source DB:  PubMed          Journal:  Nucl Med Rev Cent East Eur        ISSN: 1506-9680


  4 in total

1.  An incidentally detected breast cancer on tc-99m MIBI cardiac scintigraphy.

Authors:  Duray Seker; Gaye Seker; Emine Ozturk; Bahattin Bayar; Hakan Kulacoglu
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

Review 2.  Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.

Authors:  Laleh Amiri-Kordestani; Agnes Basseville; Karen Kurdziel; Antonio Tito Fojo; Susan E Bates
Journal:  Drug Resist Updat       Date:  2012-03-29       Impact factor: 18.500

Review 3.  Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.

Authors:  Shuang Cai; Taryn R Bagby; M Laird Forrest
Journal:  Ther Deliv       Date:  2011-11

4.  Prospective Randomized Trial of Use of In-House Prepared Low-Cost Radiopharmaceutical Versus Commercial Radiopharmaceutical for Sentinel Lymph Node Biopsy in Patients with Early Stage Invasive Breast Cancer.

Authors:  Gaurav Agarwal; Sendhil Rajan; Sabaretnam Mayilvaganan; Anjali Mishra; Narendra Krishnani; Sanjay Gambhir
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.